Article Information
vol. 9 no. 419
- Received for publication June 21, 2017
- Accepted for publication October 13, 2017
- .
Author Information
- Michael C. Sneller1,
- J. Shawn Justement1,
- Kathleen R. Gittens2,
- Mary E. Petrone1,
- Katherine E. Clarridge1,
- Michael A. Proschan3,
- Richard Kwan2,
- Victoria Shi1,
- Jana Blazkova1,
- Eric W. Refsland1,
- Daryl E. Morris4,
- Kristen W. Cohen4,
- M. Juliana McElrath4,5,
- Rong Xu6,
- Michael A. Egan6,
- John H. Eldridge6,
- Erika Benko7,
- Colin Kovacs7,8,
- Susan Moir1,
- Tae-Wook Chun1,*,† and
- Anthony S. Fauci1,*
- 1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
- 2Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD 20892, USA.
- 3Biostatistics Research Branch, NIAID, NIH, Bethesda, MD 20892, USA.
- 4Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
- 5Department of Global Health, University of Washington, Seattle, WA 98195, USA.
- 6Profectus BioSciences Inc., Tarrytown, NY 10591, USA.
- 7Maple Leaf Medical Clinic, Toronto, Ontario M5G 1K2, Canada.
- 8Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A1, Canada.
- ↵†Corresponding author. Email: twchun{at}nih.gov